193 related articles for article (PubMed ID: 34371727)
1. Meta-Analysis of Food Effect on Oral Absorption of Efflux Transporter Substrate Drugs: Does Delayed Gastric Emptying Influence Drug Transport Kinetics?
Sharma S; Prasad B
Pharmaceutics; 2021 Jul; 13(7):. PubMed ID: 34371727
[TBL] [Abstract][Full Text] [Related]
2. Interplay of metabolism and transport in determining oral drug absorption and gut wall metabolism: a simulation assessment using the "Advanced Dissolution, Absorption, Metabolism (ADAM)" model.
Darwich AS; Neuhoff S; Jamei M; Rostami-Hodjegan A
Curr Drug Metab; 2010 Nov; 11(9):716-29. PubMed ID: 21189140
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the interplay of physiological response to food intake and drug properties in food-drug interactions.
Sharma S; Kogan C; Varma MVS; Prasad B
Drug Metab Pharmacokinet; 2023 Dec; 53():100518. PubMed ID: 37856928
[TBL] [Abstract][Full Text] [Related]
4. Prediction of oral absorption of cinnarizine--a highly supersaturating poorly soluble weak base with borderline permeability.
Berlin M; Przyklenk KH; Richtberg A; Baumann W; Dressman JB
Eur J Pharm Biopharm; 2014 Nov; 88(3):795-806. PubMed ID: 25195981
[TBL] [Abstract][Full Text] [Related]
5. Using Physiologically Based Pharmacokinetic (PBPK) Modeling to Evaluate the Impact of Pharmaceutical Excipients on Oral Drug Absorption: Sensitivity Analyses.
Chow EC; Talattof A; Tsakalozou E; Fan J; Zhao L; Zhang X
AAPS J; 2016 Nov; 18(6):1500-1511. PubMed ID: 27520379
[TBL] [Abstract][Full Text] [Related]
6. Improving Dissolution Behavior and Oral Absorption of Drugs with pH-Dependent Solubility Using pH Modifiers: A Physiologically Realistic Mass Transport Analysis.
Salehi N; Kuminek G; Al-Gousous J; Sperry DC; Greenwood DE; Waltz NM; Amidon GL; Ziff RM; Amidon GE
Mol Pharm; 2021 Sep; 18(9):3326-3341. PubMed ID: 34428047
[TBL] [Abstract][Full Text] [Related]
7. A comprehensive account on the role of efflux transporters in the gastrointestinal absorption of 13 commonly used substrate drugs in humans.
Chiou WL; Chung SM; Wu TC; Ma C
Int J Clin Pharmacol Ther; 2001 Mar; 39(3):93-101. PubMed ID: 11396754
[TBL] [Abstract][Full Text] [Related]
8. Prediction of food effects on the absorption of celecoxib based on biorelevant dissolution testing coupled with physiologically based pharmacokinetic modeling.
Shono Y; Jantratid E; Janssen N; Kesisoglou F; Mao Y; Vertzoni M; Reppas C; Dressman JB
Eur J Pharm Biopharm; 2009 Sep; 73(1):107-14. PubMed ID: 19465123
[TBL] [Abstract][Full Text] [Related]
9. Advances and challenges in PBPK modeling--Analysis of factors contributing to the oral absorption of atazanavir, a poorly soluble weak base.
Berlin M; Ruff A; Kesisoglou F; Xu W; Wang MH; Dressman JB
Eur J Pharm Biopharm; 2015 Jun; 93():267-80. PubMed ID: 25872159
[TBL] [Abstract][Full Text] [Related]
10. Understanding
B Shekhawat P; B Pokharkar V
Acta Pharm Sin B; 2017 May; 7(3):260-280. PubMed ID: 28540164
[TBL] [Abstract][Full Text] [Related]
11. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Physiologically Based Pharmacokinetic Models to Predict the Absorption of BCS Class I Drugs in Different Pediatric Age Groups.
Liu XI; van den Anker JN; Burckart GJ; Dallmann A
J Clin Pharmacol; 2021 Jun; 61 Suppl 1():S94-S107. PubMed ID: 34185902
[TBL] [Abstract][Full Text] [Related]
13. Drug absorption in gastrointestinal disease with particular reference to malabsorption syndromes.
Parsons RL
Clin Pharmacokinet; 1977; 2(1):45-60. PubMed ID: 322910
[TBL] [Abstract][Full Text] [Related]
14. Predicting Food Effects on Oral Extended-Release Drug Products: A Retrospective Evaluation.
Zou P; Vaidyanathan J; Tran D; Raines K; Chatterjee P; Madabushi R; Seo SK
AAPS J; 2023 Mar; 25(3):33. PubMed ID: 36991196
[TBL] [Abstract][Full Text] [Related]
15. Predicting pharmacokinetic food effects using biorelevant solubility media and physiologically based modelling.
Jones HM; Parrott N; Ohlenbusch G; Lavé T
Clin Pharmacokinet; 2006; 45(12):1213-26. PubMed ID: 17112297
[TBL] [Abstract][Full Text] [Related]
16. In Vivo Dissolution and Systemic Absorption of Immediate Release Ibuprofen in Human Gastrointestinal Tract under Fed and Fasted Conditions.
Koenigsknecht MJ; Baker JR; Wen B; Frances A; Zhang H; Yu A; Zhao T; Tsume Y; Pai MP; Bleske BE; Zhang X; Lionberger R; Lee A; Amidon GL; Hasler WL; Sun D
Mol Pharm; 2017 Dec; 14(12):4295-4304. PubMed ID: 28937221
[TBL] [Abstract][Full Text] [Related]
17. Quantitative prediction of formulation-specific food effects and their population variability from in vitro data with the physiologically-based ADAM model: a case study using the BCS/BDDCS Class II drug nifedipine.
Patel N; Polak S; Jamei M; Rostami-Hodjegan A; Turner DB
Eur J Pharm Sci; 2014 Jun; 57():240-9. PubMed ID: 24060671
[TBL] [Abstract][Full Text] [Related]
18. Use of Physiologically Based Pharmacokinetic Modeling for Predicting Drug-Food Interactions: Recommendations for Improving Predictive Performance of Low Confidence Food Effect Models.
Wagner C; Kesisoglou F; Pepin XJH; Parrott N; Emami Riedmaier A
AAPS J; 2021 Jun; 23(4):85. PubMed ID: 34142242
[TBL] [Abstract][Full Text] [Related]
19. Identification of intestinal loss of a drug through physiologically based pharmacokinetic simulation of plasma concentration-time profiles.
Peters SA
Clin Pharmacokinet; 2008; 47(4):245-59. PubMed ID: 18336054
[TBL] [Abstract][Full Text] [Related]
20. Effect of surfactants, gastric emptying, and dosage form on supersaturation of dipyridamole in an in vitro model simulating the stomach and duodenum.
Mitra A; Fadda HM
Mol Pharm; 2014 Aug; 11(8):2835-44. PubMed ID: 25025699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]